Navigation Links
Limited Healthcare Infrastructure and Weak Intellectual Property Protection are Among the Challenges Pharma Faces with Emerging Market Expansion

WALTHAM, Mass., March 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that pharmaceutical companies entering emerging markets must be prepared for market conditions that differ substantially from those of mature markets, including deficient healthcare infrastructures and logistical difficulties in reaching consumers in remote rural markets.

The new report entitled Strategic Overview of Pricing and Reimbursement in the BRIC Markets -- Brazil, Russia, India and China -- also finds that pharmaceutical companies will need to address weak intellectual property protection as well as governments that may not be supportive of large foreign pharmaceutical companies' efforts to establish a strong market presence.

For example, senior Russian government officials have talked of the possibility of revoking the data exclusivity agreement that guarantees at least six years of protection against unfair commercial use of data in Russia. In India, multinationals have had to resort to litigation to defend their brands' market exclusivity. In China, numerous international brands have lost sales to Chinese copy products that were approved shortly before or after the multinational originator companies received marketing approval for the new chemical entities. Multinationals also are concerned that governments in emerging markets might increase their use of compulsory licenses to ensure that key medicines are available to their citizens at relatively low prices.

Yet, despite these challenges, emerging markets offer significant growth opportunity because of thriving economies, unmet medical needs, increasing healthcare investment and growing patient populations. The BRIC markets in particular have been the focus of pharmaceutical industry attention for potential growth.

"Faced with declining growth rates in mature markets, pharmaceutical companies are looking to emerging markets, especially the BRIC markets, to boost their sales significantly," said Neil Grubert, M.A., Director of Pricing and Reimbursement Research at Decision Resources. "These markets certainly offer exciting opportunities, but they also present some formidable challenges for multinationals that are unfamiliar with the very different market dynamics in these countries."


Members of the media are welcome to attend our upcoming webinar entitled Building in BRIC -- Negotiating the Challenges and Capitalizing on the Opportunities in Emerging Markets. This webinar will be held on Thursday, March 18 at 10 a.m. U.S. Eastern Time. For more information, please contact Lisa Osgood at 781-296-2606 or by email at

About Strategic Overview Reports

Strategic Overview reports are a new offering within the Spectrum franchise. These reports are comprehensive examinations of dynamic biopharmaceutical markets and industry issues. Primary research, data analysis, thought-leader consultation and the expertise of the industry-savvy Spectrum staff drive reports that offer breadth of coverage along with depth of strategic insight.

About Decision Resources

Decision Resources ( is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

SOURCE Decision Resources

Back to top



SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
2. New Bisphenol A Study Has Limited Capability to Assess Human Health Effects
3. Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery
4. New Bisphenol A Study Is of Very Limited Relevance to Human Health
5. Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million
6. QRxPharma Limited Announces A$21.6 Million Fully Underwritten Capital Raising
7. WellTek Subsidiary MedX Limited Increases Presence in Global Market
8. Pipeline/Commercial Insight: Supportive Care in Oncology - Innovation and Market Growth Limited to Bone Metastases Management and Emerging Supportive Care Challenges Reports Now Available on ReportsandReports
9. QRxPharma Limited and China Aoxing Pharmaceutical Company Announce Strategic Alliance for Development of MoxDuo(R)IV
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
(Date:11/25/2015)... , Nov. 26, 2015  The total global healthcare ... 7% over 2015-2016. Latin America has ... , (excluding Japan ), is second ... continues to face increased healthcare expenditure. In 2013-2014, total ... declined from 43.5% in 2008-2009 to 41.2% in 2013-2014. In ...
(Date:11/25/2015)... 2015 AAIPharma Services Corp./Cambridge Major Laboratories, ... least $15.8  Million to expand its laboratories and ... . The expansion will provide additional office space ... demands of the pharmaceutical and biotechnology markets. ... provide up to 40,000 square feet of expanded ...
(Date:11/25/2015)... Israel , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused ... treatment of various clinical conditions, today announced the closing ... American Depository Shares ( ADSs ), each representing 20 ... up to 3,158,900 ADSs. The ADSs and warrants were ...
Breaking Medicine Technology:
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... ... use in Final Cut Pro X. With ProSidebar: Fasion, video editors can easily ... use ProSidebar as a minimalist title opener. Utilize presets featuring self-animating drop zones, ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... prided itself for not only fulfilling the needs of advisers and clients but ... affordable price and providing top-tier customer service. However, there's always room for improvement, ...
(Date:11/27/2015)... ... 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his ... is one of Joplin's most famous and beautiful concert posters. The concert was held ... Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's stardom ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... American Express Travel Representative. As a franchise owner, Somu now offers travelers, value ... cruise, destination wedding packages, private cruise sales, as well as, cabin upgrades and ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings ... with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired ... font, giving users limitless opportunities to stylize and create designs quickly and easily, ...
Breaking Medicine News(10 mins):